SP-2 also inhibited angiogenesis by reducing HIF-1α and VEGF in the glioblastoma cells [35], suggesting that SP-2 has the potential to regulate the HIF-1α-associated pathways and to change cellular and genomic regulation [55,56,57]. Here, SP2 is linked to glioblastoma.